DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Dietrich N, Kolibabka M, Busch S. et al.
The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy.
PLoS One 2016;
11: e0167853
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.